DrugPatentWatch Database Preview
ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER Drug Profile
Email this page to a colleague
See Plans and PricingWhich patents cover Esmolol Hydrochloride Double Strength In Plastic Container, and when can generic versions of Esmolol Hydrochloride Double Strength In Plastic Container launch?
Esmolol Hydrochloride Double Strength In Plastic Container is a drug marketed by Hq Spclt Pharma and is included in one NDA. There are four patents protecting this drug.
This drug has forty-three patent family members in twenty-five countries.
The generic ingredient in ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER is esmolol hydrochloride. There are eight drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the esmolol hydrochloride profile page.
US ANDA Litigation and Generic Entry Outlook for Esmolol Hydrochloride Double Strength In Plastic Container
A generic version of ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER was approved as esmolol hydrochloride by WEST-WARD PHARMS INT on August 10th, 2004.
Summary for ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER
| International Patents: | 43 |
| US Patents: | 4 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Clinical Trials: | 79 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER |
| DailyMed Link: | ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| David N. Proctor, PhD | Early Phase 1 |
| Ain Shams University | Phase 4 |
| Ain Shams University | Phase 3 |
See all ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER clinical trials
Recent Litigation for ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER
Identify potential future generic entrants
District Court Litigation
| Case Name | Date |
|---|---|
| BAXTER HEALTHCARE CORPORATION v. AGILA SPECIALTIES PRIVATE LIMITED | 2014-11-12 |
| BAXTER HEALTHCARE CORPORATION v. HQ SPECIALTY PHARMA CORPORATION | 2013-10-18 |
| BAXTER HEALTHCARE CORPORATION v. AGILA SPECIALTIES PRIVATE LIMITED |
See all ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER litigation
PTAB Litigation
| Petitioner | Date |
|---|---|
| 2015-11-19 |
See all ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER litigation
Pharmacology for ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER
| Drug Class | beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists |
US Patents and Regulatory Information for ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER
International Patents for ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 02076446 | Start Trial |
| Czech Republic | 20023825 | Start Trial |
| Canada | 2410446 | Start Trial |
| Canada | 2906031 | Start Trial |
| Poland | 357387 | Start Trial |
| Argentina | 098013 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
